Experienced growth-stage investor and operator with sector focus on software and fintech. Kyle Jones brings a background in product leadership and venture investing, advising portfolio companies on go-to-market, unit economics and scaling customer acquisition. Prior roles include operating leadership at late-stage startups and investment work at a venture firm; holds an MBA and engineering undergrad. Active on early growth and Series A allocations.
Experienced growth-stage investor and operator with sector focus on software and fintech. Kyle Jones brings a background in product leadership and venture investing, advising portfolio companies on go-to-market, unit economics and scaling customer acquisition. Prior roles include operating leadership at late-stage startups and investment work at a venture firm; holds an MBA and engineering undergrad. Active on early growth and Series A allocations.
Targets growth-stage software and fintech businesses, favoring Series A and early growth rounds where product-led scaling meets repeatable unit economics. Investment style combines operator lens with venture discipline: prioritize founders with defensible product differentiation, data-driven go-to-market plans, and clear customer economics. Capital allocated to accelerate customer acquisition and measurable CAC payback, with active board/advisory involvement to shape product roadmap, metrics and scalable sales motions over a 3–7 year return horizon.
Targets growth-stage software and fintech businesses, favoring Series A and early growth rounds where product-led scaling meets repeatable unit economics. Investment style combines operator lens with venture discipline: prioritize founders with defensible product differentiation, data-driven go-to-market plans, and clear customer economics. Capital allocated to accelerate customer acquisition and measurable CAC payback, with active board/advisory involvement to shape product roadmap, metrics and scalable sales motions over a 3–7 year return horizon.
| Trades 3304 | Longs Won 2126/3304 64% | Profit Factor 5.97 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $228,845.86 |
| Average Win $31,036.47 | Best Trade (Oct 15) $6.12M | Sharpe Ratio -14.29 |
| Average Loss -$9,378.75 | Worst Trade (Oct 15) -$2.01M | Z-Score -0.82 (58.51%) |
| Commissions $0 | Avg. Trade Length 1y 2w 6d | Expectancy $16,626.93 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 38,462 | 34,615 | 30,769 | 26,923 | 23,077 | 19,231 | 15,385 | 11,538 | 7,692 | 3,846 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 26 | $3,614.76 | $4,505.28 | - | $890.52 | 24.64% | -1.293% |
AAL American Airlines Group Inc. | 61 | $838 | $731.69 | - | -$106.31 | -12.69% | -2.321% |
AAPL Apple Inc. | 1,819 | $439,296.74 | $623,971.57 | - | $184,674.83 | 42.04% | +0.301% |
ABBV AbbVie Inc. | 485 | $80,335.46 | $138,205.6 | - | $57,870.14 | 72.04% | +0.55% |
ABNB Airbnb, Inc. | 2 | $253.6 | $344.88 | - | $91.28 | 35.99% | -1.056% |
ABT Abbott Laboratories | 337 | $39,908.83 | $35,273.79 | - | -$4,635.04 | -11.61% | -0.01% |
ACGL Arch Capital Group Ltd | 27 | $2,552.93 | $2,705.67 | - | $152.74 | 5.98% | +0.906% |
ACN Accenture plc Class A | 24 | $7,808.01 | $5,389.2 | - | -$2,418.81 | -30.98% | -0.165% |
ACWV iShares MSCI Global Minimum Volatility ETF | 277 | $27,873.1 | $35,212.24 | - | $7,339.14 | 26.33% | -0.094% |
ADAM Adamas Trust, Inc. | 143 | $1,183.45 | $1,091.8 | - | -$91.65 | -7.74% | -1.99% |
ADI Analog Devices, Inc. | 51 | $10,808.71 | $20,619.04 | - | $9,810.33 | 90.76% | +0.085% |
ADM Archer-Daniels-Midland Co | 52 | $2,630.52 | $4,318.08 | - | $1,687.56 | 64.15% | +0.133% |
ADP Automatic Data Processing Inc. | 18 | $4,347.43 | $5,147.19 | - | $799.76 | 18.4% | +0.107% |
AEE Ameren Corporation | 3,249 | $297,485.15 | $343,159.38 | - | $45,674.23 | 15.35% | +1.793% |
AFL Aflac Inc. | 1,148 | $95,371.8 | $136,325 | - | $40,953.2 | 42.94% | +0.593% |
AGG iShares Core U.S. Aggregate Bond ETF | 49 | $4,950.87 | $4,670.43 | - | -$280.44 | -5.66% | -0.1% |
AGNT eXp World Holdings Inc. | 1,098 | $16,896.87 | $4,188.87 | - | -$12,708 | -75.21% | -2.43% |
AJG Arthur J. Gallagher & Co. | 25 | $6,251 | $6,285.5 | - | $34.5 | 0.55% | +0.528% |
ALDX Aldeyra Therapeutics Inc. | 600 | $3,132 | $405.06 | - | -$2,726.94 | -87.07% | -8.399% |
ALGN Align Technology, Inc. | 21 | $3,076.29 | $3,098.65 | - | $22.36 | 0.73% | -1.195% |